Generation 5 (G5) poly(amidoamine) dendrimers with acetyl (G5.NHAc), glycidol hydroxyl (G5.NGlyOH), and succinamic acid (G5.SAH) terminal groups were used to physically encapsulate an anticancer drug doxorubicin (DOX). Both UV-vis spectroscopy and multiple NMR techniques including one-dimensional NMR and two-dimensional NMR were applied to investigate the interactions between different dendrimers and DOX. The influence of the surface functional groups of G5 dendrimers on the DOX encapsulation, release kinetics, and cancer cell inhibition effect was investigated. We show that all three types of dendrimers are able to effectively encapsulate DOX and display therapeutic inhibition effect to cancer cells, which is solely associated with the loaded DOX. The relatively stronger interactions of G5.NHAc or G5.NGlyOH dendrimers with DOX than that of G5.SAH dendrimers with DOX demonstrated by NMR techniques correlate well with the slow release rate of DOX from G5.NHAc/DOX or G5.NGlyOH/DOX complexes. In contrast, the demonstrated weak interaction between G5.SAH and DOX causes a fast release of DOX, suggesting that the G5.SAH/DOX complex may not be a proper option for further in vivo research. Our findings suggest that the dendrimer surface functional groups are crucial for further design of multifunctional dendrimer-based drug delivery systems for various biomedical applications.

Lithium‐ion batteries (LIBs) have been occupying the dominant position in energy storage devices. Over the past 30 years, silicon (Si)‐based materials are the most promising alternatives for graphite as LIB anodes due to their high theoretical capacities and low operating voltages. Nevertheless, their extensive volume changes in battery operation causes the structural collapse of Si‐based electrodes, as well as severe side reactions. In this review, the preparation methods and structure optimizations of Si‐based materials are highlighted, as well as their applications in half and full cells. Meanwhile, the developments of promising electrolytes, binders and separators that match Si‐based electrodes in half and full cells have made great progress. Pre‐lithiation technology has been introduced to compensate for irreversible Li+ consumption during battery operation, thereby improving the energy densities and lifetime of Si‐based full cells. More importantly, almost all related mechanisms of Si‐based electrodes in half and full cells are summarized in detail. It is expected to provide a comprehensive insight on how to develop high‐performance Si‐based full cells. The work can help us understand what happens during the lithiation process, the primary causes of Si‐based half and full cells failure, and strategies to overcome these challenges.

A low-toxic difunctional nanoplatform integrating both photothermal therapy and chemotherapy for killing cancer cells using Cu₂-xSe@mSiO₂-PEG core-shell nanoparticles is reported. Silica coating and further PEG modification improve the hydrophilicity and biocompatibility of copper selenide nanoparticles. As-prepared Cu₂-xSe@mSiO₂-PEG nanoparticles not only display strong near infrared (NIR) region absorption and good photothermal effect, but also exhibit excellent biocompatibility. The mesoporous silica shell is provided as the carrier for loading the anticancer drug, doxorubicin (DOX). Moreover, the release of DOX from Cu₂-xSe@mSiO₂-PEG core-shell nanoparticles can be triggered by pH and NIR light, resulting in a synergistic effect for killing cancer cells. Importantly, the combination of photothermal therapy and chemotherapy driven by NIR radiation with safe power density significantly improves the therapeutic efficacy, and demonstrates better therapeutic effects for cancer treatment than individual therapy.

Direct ethanol fuel cells (DEFCs) have emerged as promising and advanced power systems that can considerably reduce fossil fuel dependence, and thus have attracted worldwide attention. DEFCs have many apparent merits over the analogous devices fed with hydrogen or methanol. As the key constituents, the catalysts for both cathodes and anodes usually face some problems (such as high cost, low conversion efficiency, and inferior durability) that hinder the commercialization of DEFCs. This review mainly focuses on the most recent advances in nanostructured catalysts for anode materials in DEFCS. First, we summarize the effective strategies used to achieve highly active Pt- and Pd-based catalysts for ethanol electro-oxidation, including composition control, microstructure design, and the optimization of support materials. Second, a few non-precious catalysts based on transition metals (such as Fe, Co, and Ni) are introduced. Finally, we outline the concerns and future development of anode catalysts for DEFCs. This review provides a comprehensive understanding of anode catalysts for ethanol oxidation in DEFCs.

While silicon is considered one of the most promising anode materials for the next generation of high‐energy lithium‐ion batteries (LIBs), the industrialization of Si anodes is hampered by the anode's large volume change during the charging and discharging process. In comparison to the traditional graphite anode used in LIBs, the Si anode places more stringent demands on the binder, which must maintain intimate contact between the electrode components and the integrity of the ion and electron transport channels when subjected to frequent large volume changes. The purpose of this review is to cover the recent advances in binder design strategies by examining the molecular structure, chemical functionalities, physical and mechanical properties of the binder materials, as well as the working strategies involved. The challenges in the design of the innovative polymer binder for commercializing Si anodes are discussed, as well as the future development direction and application prospects.

Recently, metal phosphides have been extensively investigated as promising anode materials for rechargeable batteries ascribing to their good electrical conductivities and favorable electrochemical performances. These materials usually exhibit conversion-type (and...

We present here the development of multifunctional doxorubicin (DOX)-conjugated poly(amidoamine) (PAMAM) dendrimers as a unique platform for pH-responsive drug release and targeted chemotherapy of cancer cells. In this work, we covalently conjugated DOX onto the periphery of partially acetylated and folic acid (FA)-modified generation 5 (G5) PAMAM dendrimers through a pH-sensitive cis-aconityl linkage to form the G5.NHAc-FA-DOX conjugates. The formed dendrimer conjugates were well characterized using different methods. We show that DOX release from the G5.NHAc-FA-DOX conjugates follows an acid-triggered manner with a higher release rate under an acidic pH condition (pH = 5 or 6, close to the acidic pH of tumor microenvironment) than under a physiological pH condition. Both in vitro cytotoxicity evaluation and cell morphological observation demonstrate that the therapeutic activity of dendrimer-DOX conjugates against cancer cells is absolutely related to the DOX drug released. More importantly, the FA conjugation onto the dendrimers allowed a specific targeting to cancer cells overexpressing FA receptors (FAR), and allowed targeted inhibition of cancer cells. The developed G5.NHAc-FA-DOX conjugates may be used as a promising nanodevice for targeted cancer chemotherapy.

Multifunctional generation 5-poly(amidoamine) dendrimers can be used as a platform to conjugate covalently alpha-tocopheryl succinate for targeted cancer therapy.